izvor podataka: crosbi
!
The risk of relapse after discontinuation of biological therapy in crohn's disease patients – inital experience in a tertiary centre. (CROSBI ID 607125)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Sremac, Maja ; Brinar, Marko ; Turk, Nikša ; Crnčević Urek, Marija ; Krznarić, Željko ; Vucelić, Boris
The risk of relapse after discontinuation of biological therapy in crohn's disease patients – inital experience in a tertiary centre. // Falk Symposium London 2013. Abstract book. 2013
Podaci o odgovornosti
Sremac, Maja ; Brinar, Marko ; Turk, Nikša ; Crnčević Urek, Marija ; Krznarić, Željko ; Vucelić, Boris
engleski
The risk of relapse after discontinuation of biological therapy in crohn's disease patients – inital experience in a tertiary centre.
The risk of relapse after discontinuation of biological therapy in crohn's disease patients – inital experience in a tertiary centre.
Crohn's disease; relapse; biological therapy
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
2013.
objavljeno
Podaci o matičnoj publikaciji
Falk Symposium London 2013. Abstract book
Podaci o skupu
Falk symposium
poster
03.10.2013-04.10.2013
London, Ujedinjeno Kraljevstvo
Povezanost rada
Povezane osobe
Povezane ustanove
